Skip to main content

Acquired Risk Factors for Colorectal Cancer

  • Protocol
Cancer Epidemiology

Part of the book series: Methods in Molecular Biology ((MIMB,volume 472))

Abstract

The risk of developing colorectal cancer (CRC) is influenced by several acquired risk factors, including environmental exposures and comorbid medical conditions that are partially genetic in nature. These risk factors are based on data almost exclusively derived from observational studies. Because of the possibility of bias due to confounding, these acquired risk factors should not be automatically assumed to be causative, and in fact some may not be truly independent risk factors. Acquired risk factors include the following categories: 1) dietary factors, 2) lifestyle factors, 3) side-effects of medical interventions, and 4) comorbid medical conditions.

Dietary factors that potentially increase the risk of CRC include low fruit, vegetable, or fiber intake, high red meat or saturated fat consumption, and exposure to caffeine or alcohol. Of these factors, the significance of low fruit, vegetable, and fiber intake has been called into question because of contradictory results from large observational studies and negative results from randomized trials. The association of high red meat or saturated fat consumption with increased CRC risk is supported by the preponderance of observational data. Lifestyle factors include lack of exercise and smoking. These risk factors are supported by observational data of moderate quality.

Medical interventions that may increase the risk of CRC include pelvic irradiation, cholecystectomy, and ureterocolic anastomosis after major surgery of the urinary and intestinal tracts. Aside from cholecystec-tomy, these risk factors are supported by observational data from small studies only, therefore their validity is not well established.

Finally, comorbid medical conditions that are associated with increased risk of CRC include Barrett's esophagus, human immunodeficiency virus infection, acromegaly, and inflammatory bowel disease. The association between inflammatory bowel disease and CRC is well established and it forms the basis for widely adopted colonoscopic surveillance recommendations from national medical organizations. The other factors are supported by limited observational data only and are still controversial.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Terry P, Giovannucci E, Michels KB, Bergkvist L, Hansen H, Holmberg L, et al. (2001) Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst 93, 525–533.

    CAS  PubMed  Google Scholar 

  2. Slattery ML, Boucher KM, Caan BJ, Potter JD, and Ma KN. Eating patterns and risk of colon cancer (1998) Am J Epidemiol 148, 4–16.

    CAS  PubMed  Google Scholar 

  3. Negri E, Franceschi S, Parpinel M, and La Vecchia C. (1998) Fiber intake and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 7, 667–671.

    CAS  PubMed  Google Scholar 

  4. Peters U, Sinha R, Chatterjee N, Subar AF, Ziegler RG, Kulldorff M, et al. (2003) Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 361, 1491–1495.

    PubMed  Google Scholar 

  5. Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, Norat T, et al. (2203) Dietary fibre in food and protection against color-ectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 361, 1496–1501.

    Google Scholar 

  6. Larsson SC, Giovannucci E, Bergkvist L, and Wolk A. (2005) Whole grain consumption and risk of colorectal cancer: a population-based cohort of 60,000 women. Br J Cancer 92, 1803–1807.

    CAS  PubMed  Google Scholar 

  7. Michels KB, Edward G, Joshipura KJ, Rosner BA, Stampfer MJ, Fuchs CS, et al. (2000) Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst 92, 1740–1752.

    CAS  PubMed  Google Scholar 

  8. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Stampfer MJ, Rosner B, et al. (1999) Dietary fiber and the risk of color-ectal cancer and adenoma in women. N Engl J Med 340, 169–176.

    CAS  PubMed  Google Scholar 

  9. Schatzkin A, Lanza E, Corle D, Lance P, Iber F, Caan B, et al. (2000) Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med 342, 1149–1155.

    CAS  PubMed  Google Scholar 

  10. Alberts DS, Martinez ME, Roe DJ, Guillen-Rodriguez JM, Marshall JR, van Leeuwen JB, et al. (2000) Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med 342, 1156–1162.

    CAS  PubMed  Google Scholar 

  11. Beresford SA, Johnson KC, Ritenbaugh C, Lasser NL, Snetselaar LG, Black HR, et al. (2006) Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295, 643–654.

    CAS  PubMed  Google Scholar 

  12. Asano T and McLeod RS. (2002) Dietary fibre for the prevention of colorectal adenomas and carcinomas. Cochrane Database Syst Rev 2, CD003430.

    Google Scholar 

  13. Park Y, Hunter DJ, Spiegelman D, Bergkvist L, Berrino F, van den Brandt PA, et al. (2005) Dietary fiber intake and risk of colorectal cancer: a pooled analysis of pros-pective cohort studies. JAMA 294, 2849–2857.

    CAS  PubMed  Google Scholar 

  14. Chao A, Thun MJ, Connell CJ, McCul-lough ML, Jacobs EJ, Flanders WD, et al. (2005) Meat consumption and risk of color-ectal cancer. JAMA 293, 172–182.

    CAS  PubMed  Google Scholar 

  15. Jarvinen R, Knekt P, Hakulinen T, Rissanen H, and Heliovaara M. (2001) Dietary fat, cholesterol and colorectal cancer in a prospective study. Br J Cancer 85, 357–361.

    CAS  PubMed  Google Scholar 

  16. Butler LM, Sinha R, Millikan RC, Martin CF, Newman B, Gammon MD, et al. (2003) Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. Am J Epidemiol 157, 434–445.

    CAS  PubMed  Google Scholar 

  17. Larsson SC, Rafter J, Holmberg L, Berg-kvist L, and Wolk A. (2005) Red meat consumption and risk of cancers of the proximal colon, distal colon and rectum: the Swedish Mammography Cohort. Int J Cancer 113, 829–834.

    CAS  PubMed  Google Scholar 

  18. Norat T, Bingham S, Ferrari P, Slimani N, Jenab M, Mazuir M, et al. (2005) Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst 97, 906–916.

    PubMed  Google Scholar 

  19. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, and Speizer FE. (1990) Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 323, 1664–1672.

    CAS  PubMed  Google Scholar 

  20. Sanjoaquin MA, Appleby PN, Thorogood M, Mann JI, and Key TJ. (2004) Nutrition, lifestyle and colorectal cancer incidence: a prospective investigation of 10998 vegetarians and non-vegetarians in the United Kingdom. Br J Cancer 90, 118–121.

    CAS  PubMed  Google Scholar 

  21. Sandhu MS, White IR, and McPherson K. (2001) Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol Biomarkers Prev 10, 439–446.

    CAS  PubMed  Google Scholar 

  22. Pedersen A, Johansen C, and Gronbaek M. (2003) Relations between amount and type of alcohol and colon and rectal cancer in a Danish population based cohort study. Gut 52, 861–867.

    CAS  PubMed  Google Scholar 

  23. Shimizu N, Nagata C, Shimizu H, Kametani M, Takeyama N, Ohnuma T, et al. (2003) Height, weight, and alcohol consumption in relation to the risk of colorectal cancer in Japan: a prospective study. Br J Cancer 88, 1038–1043.

    CAS  PubMed  Google Scholar 

  24. Longnecker MP, Orza MJ, Adams ME, Vioque J, and Chalmers TC. (1990) A meta-analysis of alcoholic beverage consumption in relation to risk of colorectal cancer. Cancer Causes Control 1, 59–68.

    CAS  PubMed  Google Scholar 

  25. Gapstur SM, Potter JD, and Folsom AR. (1994) Alcohol consumption and colon and rectal cancer in postmenopausal women. Int J Epidemiol 23, 50–57.

    CAS  PubMed  Google Scholar 

  26. Ye W, Romelsjo A, Augustsson K, Adami HO, and Nyren O. (2003) No excess risk of colorectal cancer among alcoholics followed for up to 25 years. Br J Cancer 88, 1044–1046.

    CAS  PubMed  Google Scholar 

  27. Cho E, Smith-Warner SA, Ritz J, van den Brandt PA, Colditz GA, Folsom AR, et al. (2004) Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 140, 603–613.

    PubMed  Google Scholar 

  28. Harnack L, Jacobs DR Jr, Nicodemus K, Lazovich D, Anderson K, and Folsom AR. (2002) Relationship of folate, vitamin B-6, vitamin B-12, and methionine intake to incidence of colorectal cancers. Nutr Cancer 43, 152–158.

    CAS  PubMed  Google Scholar 

  29. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, and Willett WC. (1995) Alcohol, low-methionine–low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 87, 265–273.

    CAS  PubMed  Google Scholar 

  30. Giovannucci E. (1998) Meta-analysis of coffee consumption and risk of colorectal cancer. Am J Epidemiol 147, 1043–1052.

    CAS  PubMed  Google Scholar 

  31. Colditz GA, Cannuscio CC, and Frazier AL. (1997) Physical activity and reduced risk of colon cancer: implications for prevention. Cancer Causes Control 8, 649–667.

    CAS  PubMed  Google Scholar 

  32. Mao Y, Pan S, Wen SW, and Johnson KC. (2003) Physical inactivity, energy intake, obesity and the risk of rectal cancer in Canada. Int J Cancer 105, 831–837.

    CAS  PubMed  Google Scholar 

  33. Nilsen TI and Vatten LJ. (2001) Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperin-sulinaemia hypothesis. Br J Cancer 84, 417–422.

    CAS  PubMed  Google Scholar 

  34. Colbert LH, Hartman TJ, Malila N, Lim-burg PJ, Pietinen P, Virtamo J, et al. (2001) Physical activity in relation to cancer of the colon and rectum in a cohort of male smokers. Cancer Epidemiol Biomarkers Prev 10, 265–268.

    CAS  PubMed  Google Scholar 

  35. Sturmer T, Glynn RJ, Lee IM, Christen WG, and Hennekens CH. (2000) Lifetime cigarette smoking and colorectal cancer incidence in the Physicians' Health Study I. J Natl Cancer Inst 92, 1178–1181.

    CAS  PubMed  Google Scholar 

  36. Chao A, Thun MJ, Jacobs EJ, Henley SJ, Rodriguez C, and Calle EE. (2000) Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst 92, 1888–1896.

    CAS  PubMed  Google Scholar 

  37. Colangelo LA, Gapstur SM, Gann PH, and Dyer AR. (2004) Cigarette smoking and colorectal carcinoma mortality in a cohort with long-term follow-up. Cancer 100, 288–293.

    PubMed  Google Scholar 

  38. Sandler RS and Sandler DP. (1983) Radiation-induced cancers of the colon and rectum: assessing the risk. Gastroenterology 84, 51–57.

    CAS  PubMed  Google Scholar 

  39. Baxter NN, Tepper JE, Durham SB, Rothenberger DA, and Virnig BA. (2005) Increased risk of rectal cancer after prostate radiation: a population-based study. Gas-troenterology 128, 819–824.

    Google Scholar 

  40. Lagergren J, Ye W, and Ekbom A. (2001) Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis? Gastroente-rology 121, 542–547.

    CAS  Google Scholar 

  41. Todoroki I, Friedman GD, Slattery ML, Potter JD, and Samowitz W. (1999) Chole-cystectomy and the risk of colon cancer. Am J Gastroenterol 94, 41–46.

    CAS  PubMed  Google Scholar 

  42. Mercer PM, Reid FD, Harrison M, and Bates T. (1995) The relationship between cholecystectomy, unoperated gallstone disease, and colorectal cancer. A necropsy study. Scand J Gastroenterol 30, 1017–1020.

    CAS  PubMed  Google Scholar 

  43. Giovannucci E, Colditz GA, and Stampfer MJ. (1993) A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastro-enterology 105, 130–141.

    CAS  Google Scholar 

  44. Reid FD, Mercer PM, harrison M, and Bates T. (1996) Cholecystectomy as a risk factor for colorectal cancer: a meta-analysis. Scand J Gastroenterol 31, 160–169.

    CAS  PubMed  Google Scholar 

  45. Stewart M, Macrae FA, and Williams CB. (1982) Neoplasia and ureterosigmoidos-tomy: a colonoscopy survey. Br J Surg 69, 414–416.

    CAS  PubMed  Google Scholar 

  46. Azimuddin K, Khubchandani IT, Stasik JJ, Rosen L, and Riether RD. (1999) Neopla-sia after ureterosigmoidostomy. Dis Colon Rectum 42, 1632–1638.

    CAS  PubMed  Google Scholar 

  47. Siersema PD, Yu S, Sahbaie P, Steyerberg EW, Simpson PW, Kuipers EJ, et al. (2006) Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Gastrointest Endosc 63, 581–586.

    PubMed  Google Scholar 

  48. Sontag SJ, Schnell TG, Chejfec G, O'Connell S, Stanley MM, Best W, et al. (1985) Barrett's oesophagus and colonic tumours. Lancet 1, 946–949.

    CAS  PubMed  Google Scholar 

  49. Vaughan TL, Kiemeney LA, and McKnight B. (1995) Colorectal cancer in patients with esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 4, 93–97.

    CAS  PubMed  Google Scholar 

  50. Tripp MR, Sampliner RE, Kogan FJ, and Morgan TR. (1986) Colorectal neoplasms and Barrett's esophagus. Am J Gastroen-terol 81, 1063–1064.

    CAS  Google Scholar 

  51. Post AB, Achkar E, and Carey WD. (1993) Prevalence of colonic neoplasia in patients with Barrett's esophagus. Am J Gastroen-terol 88, 877–880.

    CAS  Google Scholar 

  52. Cauvin JM, Goldfain D, Le Rhun M, Robasz-kiewicz M, Cadiot G, Carpentier S, et al. (1995) Multicentre prospective controlled study of Barrett's oesophagus and colorectal adenomas. Groupe d'Etude de l'Oesophage de Barrett. Lancet 346, 1391–1394.

    CAS  PubMed  Google Scholar 

  53. Laitakari R, Laippala P, and Isolauri J. (1995) Barrett's oesophagus is not a risk factor for colonic neoplasia: a case-control study. Ann Med 27, 499–502.

    CAS  PubMed  Google Scholar 

  54. Poorman JC, Lieberman DA, Ippoliti AF, Weber LJ, and Weinstein WM. (1997) The prevalence of colonic neoplasia in patients with Barrett's esophagus: prospective assessment in patients 50–80 years old. Am J Gastroenterol 92, 592–596.

    CAS  PubMed  Google Scholar 

  55. Lagergren J and Nyren O. (1999) No association between colon cancer and adenocarci-noma of the oesophagus in a population based cohort study in Sweden. Gut 44, 819–821.

    CAS  PubMed  Google Scholar 

  56. Howden CW and Hornung CA. (1995) A systematic review of the association between Barrett's esophagus and colon neoplasms. Am J Gastroenterol 90, 1814–1819.

    CAS  PubMed  Google Scholar 

  57. Bini EJ, Park J, and Francois F. (2006) Use of flexible sigmoidoscopy to screen for colorectal cancer in HIV-infected patients 50 years of age and older. Arch Intern Med 166, 1626–1631.

    PubMed  Google Scholar 

  58. La Vecchia C, Negri E, Decarli A, and Franceschi S. (1997) Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 6, 1007–1010.

    CAS  PubMed  Google Scholar 

  59. Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB, et al. (1999) Prospective study of adult onset diabetes mel-litus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 91, 542–547.

    CAS  PubMed  Google Scholar 

  60. Yang YX, Hennessy S, and Lewis JD. (2005) Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol 3, 587–594.

    PubMed  Google Scholar 

  61. Larsson SC, Orsini N, and Wolk A. (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97, 1679–1687.

    PubMed  Google Scholar 

  62. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, et al. (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91, 620–625.

    CAS  PubMed  Google Scholar 

  63. Ma J, Giovannucci E, Pollak M, Leavitt A, Tao Y, Gaziano JM, et al. (2004) A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 96, 546–553.

    CAS  PubMed  Google Scholar 

  64. Yang YX, Hennessy S, and Lewis JD. (2004) Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 127, 1044–1050.

    CAS  PubMed  Google Scholar 

  65. Delhougne B, Deneux C, Abs R, Chanson P, Fierens H, Laurent-Puig P, et al. (1995) The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients. J Clin Endocrinol Metab 80, 3223–3226.

    CAS  PubMed  Google Scholar 

  66. Fukuda I, Hizuka N, Murakami Y, Itoh E, Yasumoto K, Sata A, et al. (2001) Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women's Medical University. Intern Med 40, 987–992.

    CAS  PubMed  Google Scholar 

  67. Ekbom A, Helmick C, Zack M, and Adami HO. (1990) Ulcerative colitis and color-ectal cancer. A population-based study. N Engl J Med 323, 1228–1233.

    CAS  PubMed  Google Scholar 

  68. Ekbom A, Helmick C, Zack M, and Adami HO. (1990) Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 336, 357–359.

    CAS  PubMed  Google Scholar 

  69. Hommes DW and van Deventer SJ. (2004) Endoscopy in inflammatory bowel diseases. Gastroenterology 126, 1561–1573.

    PubMed  Google Scholar 

  70. Eaden JA and Mayberry JF. (2002) Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 51 Suppl 5:V10–12.

    PubMed  Google Scholar 

  71. Kornbluth A and Sachar DB. (2004) Ulcer-ative colitis practice guidelines in adults (update): American College of Gastroen-terology, Practice Parameters Committee. Am J Gastroenterol 99, 1371–1385.

    PubMed  Google Scholar 

  72. Jess T, Loftus EV Jr, Velayos FS, Harm-sen WS, Zinsmeister AR, Smyrk TC, et al. (2006) Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted county, Minnesota. Gastroenterology 130, 1039–1046.

    PubMed  Google Scholar 

  73. Gyde SN, Prior P, Allan RN, Stevens A, Jewell DP, Truelove SC, et al. (1988) Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 29, 206–217.

    CAS  PubMed  Google Scholar 

  74. Winther KV, Jess T, Langholz E, Munkholm P, and Binder V. (2004) Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2, 1088–1095.

    PubMed  Google Scholar 

  75. Greenstein AJ, Sachar DB, Smith H, Puci-llo A, Papatestas AE, Kreel I, et al. (1979) Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroen-terology 77, 290–294.

    CAS  Google Scholar 

  76. Nugent FW, Haggitt RC, and Gilpin PA. (1991) Cancer surveillance in ulcerative colitis. Gastroenterology 100, 1241–1248.

    CAS  PubMed  Google Scholar 

  77. Levin B. (1992) Inflammatory bowel disease and colon cancer. Cancer 70, 1313–1316.

    CAS  PubMed  Google Scholar 

  78. Heuschen UA, Hinz U, Allemeyer EH, Stern J, Lucas M, Autschbach F, et al. (2001) Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology 120, 841–847.

    CAS  PubMed  Google Scholar 

  79. Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, et al. (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126, 451–459.

    PubMed  Google Scholar 

  80. Haskell H, Andrews CW Jr, Reddy SI, Dendrinos K, Farraye FA, Stucchi AF, et al. (2005) Pathologic features and clinical significance of “ backwash ” ileitis in ulcerative colitis. Am J Surg Pathol 29, 1472–1481.

    PubMed  Google Scholar 

  81. Soetikno RM, Lin OS, Heidenreich PA, Young HS, and Blackstone MO. (2002) Increased risk of colorectal neoplasia in patients with primary sclerosing cholan-gitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 56, 48–54.

    PubMed  Google Scholar 

  82. Rubio CA and Befrits R. (1997) Colorectal adenocarcinoma in Crohn's disease: a retrospective histologic study. Dis Colon Rectum 40, 1072–1078.

    CAS  PubMed  Google Scholar 

  83. Friedman S, Rubin PH, Bodian C, Goldstein E, Harpaz N, and Present DH. (2001) Screening and surveillance colonoscopy in chronic Crohn's colitis. Gastroenterology 120, 820–826.

    CAS  PubMed  Google Scholar 

  84. Maykel JA, Hagerman G, Mellgren AF, Li SY, Alavi K, Baxter NN, et al. (2006) Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients. Dis Colon Rectum 49, 950–957.

    PubMed  Google Scholar 

  85. Gyde SN, Prior P, Macartney JC, Thompson H, Waterhouse JA, and Allan RN. (1980) Malignancy in Crohn's disease. Gut 21, 1024–1029.

    CAS  PubMed  Google Scholar 

  86. Greenstein AJ, Sachar DB, Smith H, Janowitz HD, and Aufses AH, Jr. (1981) A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer 48, 2742–2745.

    CAS  PubMed  Google Scholar 

  87. Choi PM and Zelig MP. (1994) Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 35, 950–954.

    CAS  PubMed  Google Scholar 

  88. Gillen CD, Walmsley RS, Prior P, Andrews HA, and Allan RN. (1994) Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 35, 1590–1592.

    CAS  PubMed  Google Scholar 

  89. Jensen AB, Larsen M, Gislum M, Skriver MV, Jepsen P, Norgaard B, et al. Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study. Am J Gastroenterol 2006;101(6):1283–1287.

    PubMed  Google Scholar 

  90. Larsen M, Mose H, Gislum M, Skriver MV, Jepsen P, Norgard B, et al. (2007) Survival after colorectal cancer in patients with Crohn's disease: A nationwide population-based Danish follow-up study. Am J Gastro-enterol 102, 163–167.

    Google Scholar 

  91. Sugita A, Greenstein AJ, Ribeiro MB, Sachar DB, Bodian C, Panday AK, et al. (1993) Survival with colorectal cancer in ulcerative colitis. A study of 102 cases. Ann Surg 218, 189–195.

    CAS  Google Scholar 

  92. Heimann TM, Oh SC, Martinelli G, Szporn A, Luppescu N, Lembo CA, et al. (1992) Colorectal carcinoma associated with ulcerative colitis: a study of prognostic indicators. Am J Surg 164, 13–17.

    CAS  PubMed  Google Scholar 

  93. Gorfine SR, Bauer JJ, Harris MT, and Kreel I. (2000) Dysplasia complicating chronic ulcerative colitis: is immediate colec-tomy warranted? Dis Colon Rectum 43, 1575–1581.

    CAS  PubMed  Google Scholar 

  94. Ullman T, Croog V, Harpaz N, Sachar D, and Itzkowitz S. (2003) Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroen-terology 125, 1311–1319.

    Google Scholar 

  95. Lim CH, Dixon MF, Vail A, Forman D, Lynch DA, and Axon AT. (2003) Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut 52, 1127–1132.

    CAS  PubMed  Google Scholar 

  96. Jess T, Loftus EV Jr, Velayos FS, Harm-sen WS, Zinsmeister AR, Smyrk TC, et al. (2006) Incidence and prognosis of colorec-tal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Inflamm Bowel Dis 12, 669–676.

    PubMed  Google Scholar 

  97. Befrits R, Ljung T, Jaramillo E, and Rubio C. (2002) Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. Dis Colon Rectum 45, 615–620.

    CAS  PubMed  Google Scholar 

  98. Blackstone MO, Riddell RH, Rogers BH, and Levin B. (1981) Dysplasia-associated lesion or mass (DALM) detected by colon-oscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterol-ogy 80, 366–374.

    CAS  PubMed  Google Scholar 

  99. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, and Wilkinson KH. (1994) Factors affecting the outcome of endoscopic surveillance for cancer in ulcera-tive colitis. Gastroenterology 107, 934–944.

    CAS  PubMed  Google Scholar 

  100. Choi PM, Nugent FW, Schoetz DJ Jr, Silverman ML, and Haggitt RC. (1993) Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 105, 418–424.

    CAS  PubMed  Google Scholar 

  101. Karlen P, Kor nfeld D, Brostr om O, Lofberg R, Persson PG, and Ekbom A. (1998) Is colono-scopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 42, 711–714.

    CAS  PubMed  Google Scholar 

  102. Velayos FS, Loftus EV Jr, Jess T, Harmsen WS, Bida J, Zinsmeister AR, et al. (2006) Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Gastroenterology 130, 1941–1949.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Lin, O.S. (2009). Acquired Risk Factors for Colorectal Cancer. In: Verma, M. (eds) Cancer Epidemiology. Methods in Molecular Biology, vol 472. Humana Press. https://doi.org/10.1007/978-1-60327-492-0_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-492-0_16

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-491-3

  • Online ISBN: 978-1-60327-492-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics